Incorporating Indications into Medication Ordering -Time to Enter the Age of Reason
"The question is often asked, why physicians do not write . . . prescriptions in English. The answer is obvious -that if they did, the patient would often be less benefited than he now is. There are very few minds which have sufficient firmness, during the continuance of disease, to reason calmly on the probable effects of remedies, and to compare their wonted action . . . with the indication to be fulfilled in the particular case. . . . The only state in which the mind can rest . . . during severe illness, is that of implicit reliance in the skill of the physician, and an entire acquiescence in the course adopted, without the slightest question or argument." 1 In our current era of transparent, patient-centered medicine, such sentiments would hardly be accepted. Unfortunately, patients are often still in the dark regarding the purposes of their medications. It is said that there are five "rights" required for safe medication ordering and use: the right patient, the right drug, the right dose, the right time, and the right route. But there's a sixth element that must be correct -and we believe it's time to add to each prescription an ingredient that's currently conspicuously missing: the right indication. This pivotal element affects and complements the other five, and considering it a sixth "right" would inform and enhance the safety of each prescription. With most prescriptions now being written electronically, this addition is particularly timely, since electronic medication ordering provides the vehicle for incorporating the indication into prescribing -and is handicapped in various ways without it.
Indications-based prescribing can contribute to better prescribing and medication use in multiple, synergistic ways (see table) . First, when medication choices are narrowed to those indicated for a specific problem, decisions are much less prone to error. Staff and patients will be able to more easily recognize any mismatches and intercept prescribing or dispensing errors. Properly designed ordering systems could, for example, prevent common errors related to drugs whose names look and sound similar, such as inadvertent ordering of hydralazine for itching or hydroxyzine for hypertension. An indications-based computer prescribing system could render such drugindication mismatches impossible or at least make them easier for pharmacists to detect.
Second, we know that if patients are to understand and adhere to their medication regimens, they need to know the reason each medication is being prescribed. Having this knowledge has been shown to be associated with better adherence and fewer errors, 2 yet patients often do not know the indications for some or all of their medications. 3 Pharmacists, visiting nurses, and caregiving relatives also need this information, but they are often even more in the dark about the reason for a given prescription. Presented with a choice, most patients prefer instructional leaflets and prescription labels that include indications to those that don't include indications. 4 Knowledge of the indication can also empower patients to question the necessity of a medication.
Third, prescribers need and want help choosing the best drugs for their patients' problems. Busy clinicians may not have time to look up recommended choices whenever they encounter problems beyond the limited repertoire they can hold in their heads. How many physicians can keep up with and recall the current regimen for Helicobacter pylori or gonorrhea infection? With pharmacotherapy choices and regimens becoming increasingly complex, there's a need for efficient, trustworthy, timely support for prescribing decisions. Since each prescription logically starts with a clinical problem or diagnosis, we should make it easy for prescribers to enter the indication (or click on a problem from the problem list) and have the system present the best thera- peutic alternatives. This approach would not only enable the automatic capturing and recording of the indication, but also streamline prescribing with suggestions of the most appropriate choices. Ideally, such a system would be "smart" enough to base suggestions on data in the electronic medical record, including the patient's allergies (which could trigger suggestions for appropriate alternatives), prior and current medications (so that the prescriber could avoid adverse interactions or avoid unknowingly repeating drugs that had already been tried unsuccessfully), relevant contraindications, and insurance and formulary requirements. It's important that such recommendations be designed to provide sufficient flexibility to maintain prescribers' choice and autonomy.
Fourth, knowledge of indications is key to getting prescribers, pharmacists, nurses, and pa- tients on the same page regarding what is being treated and what outcomes are desired. Pharmacists who are uncertain about the reason a medication is being given will be unable to explain it to the patient. For decades, pharmacists' organizations have advocated for including indications on prescriptions, but physicians have objected that it would take them too much time. Confidentiality is another legitimate concern. However, better communication within the health care team broadly conceived is not incompatible with protecting patient confidentiality, and protections provided by the Health Insurance Portability and Accountability Act should allay this concern. For special cases (for instance, mental health or HIV infection), systems could be designed to permit prescribers or patients to easily opt out of having the indication included on the label. Fifth, problems with medication reconciliation are a substantial source of confusion and error, including inadvertent duplicate therapy and inappropriate continuation of medications that are no longer needed. Reconciling medications is now widely mandated, but when medications are listed randomly, alphabetically, or chronologically (as they generally are) rather than being organized by indication, the task is infinitely harder. Once all medications for hypertension or asthma are grouped together, duplicates that may need to be discontinued are easier to spot. Discontinuing unneeded medications is an important related task, but when one doesn't know why a medication was prescribed, guessing the indication and whether it's OK to discontinue it becomes risky.
Finally, one cannot meaningfully measure a drug's long-term effectiveness (or comparative effectiveness) without reference to the reason for its use. Including indications in prescriptions would permit clearer assessments and comparisons. Similarly, efforts to oversee and learn from patterns in prescribing practices and adherence require information about indications in order to assess appropriateness, exceptions, and off-label prescribing practices. We envision a system in which an off-label indication could easily be selected for a medication being prescribed, but in which such prescriptions could then be tracked and evaluated to inform possible labeling revisions or prescribing improvements.
Because incorporating indications into prescriptions represents such a compelling opportunity for improving the safety and quality of prescribing, the Agency for Healthcare Research and Quality has funded a 3-year project that we are spearheading that has brought together key stakeholders for seven international Web conferences to clarify the rationale behind this paradigm, the challenges to implementing it, and ways to move it forward. 5 Key to realizing universal indications-based prescribing will be designing a system that fits into and enhances workflow and leverages other information technology. Rather than burdening prescribers with adding indications to prescriptions, we are working with human-factors and usability engineers, information technology design specialists, and policy leaders to build a prototype that will allow prescribers to start from the indication or the patient's problem and will guide them toward the best choices. We will be testing our hypothesis that this system will result in a safer, more efficient way of ordering medications. We hope and expect that it can bring prescribing into the age of reason, benefiting patients, prescribers, pharmacists, and other members of the health care team. Indications are the link connecting a patient with a given drug; we believe that electronic prescribing needs to incorporate this missing link.
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